The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population -Based Cohort Study
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
Journal
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
Volume 21, Issue 6, Pages 811-816Publisher
ELSEVIER SCIENCE INC
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications
M. K. Skjodt, M. T. Ernst, S. Khalid, C. Libanati, C. Cooper, A. Delmestri, K. H. Rubin, M. K. Javaid, D. Martinez-Laguna, E. Toth, D. Prieto-Alhambra, B. Abrahamsen
OSTEOPOROSIS INTERNATIONAL (2021)
Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
Hong Jin Kim, Ha Kyun Chang, Dong-Gune Chang, JiYun Ha, Byeong-Rak Keum, Gun-Hwa Kim
JOURNAL OF CLINICAL MEDICINE (2023)
Better oral hygiene is associated with a reduced risk of osteoporotic fracture: a nationwide cohort study
Jung-Hyun Park, Moo-Seok Park, Hyung-Jun Kim, Heajung Lee, Jin-Woo Kim, Tae-Jin Song
FRONTIERS IN ENDOCRINOLOGY (2023)
Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study
Kristin M. D'Silva, Lingyi Li, Na Lu, Alexis Ogdie, J. Antonio Avina-Zubieta, Hyon K. Choi
RHEUMATOLOGY (2021)
Is Radiographic Osteoporotic Hip Morphology A Predictor For High Mortality Following Intertrochanteric Femur Fractures? Osteoporotic Hip Morphology & Mortality
Mustafa Caner Okkaoglu, Erdi Ozdemir, Ugur Yaradilmis, Murat Altay
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2022)
The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
Rikke Viggers, Zheer Al-Mashhadi, Jakob Starup-Linde, Peter Vestergaard
FRONTIERS IN ENDOCRINOLOGY (2022)
Osteoarthritis and the incidence of fracture in the United Kingdom: a retrospective cohort study of 258,696 patients
L. Jacob, K. Kostev
OSTEOARTHRITIS AND CARTILAGE (2021)
Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture
Hiroki Iida, Yoshihito Sakai, Taisuke Seki, Tsuyoshi Watanabe, Norimitsu Wakao, Hiroki Matsui, Shiro Imagama
OSTEOPOROSIS INTERNATIONAL (2022)
Orthogeriatric co-management for older patients with a major osteoporotic fracture: Protocol of an observational pre-post study
Sigrid Janssens, Marian Dejaeger, An Sermon, Katleen Fagard, Marie Cerulus, Heidi Cosyns, Johan Flamaing, Mieke Deschodt
PLOS ONE (2023)
The association of objectively ascertained sibling fracture history with major osteoporotic fractures: a population-based cohort study
A. F. Hamad, S. Yang, L. Yan, W. D. Leslie, S. N. Morin, R. Walld, L. L. Roos, L. M. Lix
OSTEOPOROSIS INTERNATIONAL (2021)
Long-term exposure to air pollution and COVID-19 severity: A cohort study in Greater Manchester, United Kingdom*
Samuel Hyman, Jiawei Zhang, Zorana Jovanovic Andersen, Sheena Cruickshank, Peter Moller, Konstantinos Daras, Richard Williams, David Topping, Youn-Hee Lim
ENVIRONMENTAL POLLUTION (2023)
Oral health inequality in Canada, the United States and United Kingdom
Malini Chari, Vahid Ravaghi, Wael Sabbah, Noha Gomaa, Sonica Singhal, Carlos Quinonez
PLOS ONE (2022)
Total Cholesterol Variability and the Risk of Osteoporotic Fractures: A Nationwide Population-Based Cohort Study
Dongyeop Kim, Jee Hyun Kim, Tae-Jin Song
JOURNAL OF PERSONALIZED MEDICINE (2023)
Impact of Stroke History on the Risk of Recurrent Hip Fracture or Major Osteoporotic Fractures among Patients with Incident Hip Fracture: A Nationwide Cohort Study
Thomas J. Hjelholt, Soren P. Johnsen, Peter K. Brynningsen, Grethe Andersen, Alma B. Pedersen
JOURNAL OF BONE AND MINERAL RESEARCH (2023)
The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis
Zohreh Safipour, Rogier van Der Zanden, Joop van den Bergh, Paddy Janssen, Peter Vestergaard, Frank de Vries, Johanna H. M. Driessen
OSTEOPOROSIS INTERNATIONAL (2022)
Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng
Shahab Abtahi, Johanna H. M. Driessen, Andrea M. Burden, Patrick C. Souverein, Joop P. van den Bergh, Tjeerd P. van Staa, Annelies Boonen, Frank de Vries
ANNALS OF THE RHEUMATIC DISEASES (2023)
Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study' by Gong and Zhang and Lin et al
Shahab Abtahi, Johanna H. M. Driessen, Andrea M. Burden, Patrick C. Souverein, Joop P. van den Bergh, Annelies Boonen
ANNALS OF THE RHEUMATIC DISEASES (2023)
His452Tyr 5-HT2A polymorphism and intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation
J. J. van Raaij, K. H. Hua, F. de Vries, Paddy K. C. Janssen
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2023)
What Is the Diagnostic Performance of Conventional Radiographs and Clinical Reassessment Compared With HR-pQCT Scaphoid Fracture Diagnosis?
Anne M. Daniels, Josephine Kranendonk, Caroline E. Wyers, Heinrich M. J. Janzing, Sander Sassen, Bert van Rietbergen, Piet P. M. M. Geusens, Sjoerd Kaarsemaker, Pascal F. W. Hannemann, Martijn Poeze, Joop P. van den Bergh
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2023)
Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997-2017)
Annika Vestergaard Kvist, Mohamad I. Nasser, Peter Vestergaard, Morten Frost, Andrea M. Burden
DIABETES CARE (2023)
CT Scan-Derived Muscle, But Not Fat, Area Independently Predicts Mortality in COVID-19
Sophie I. J. van Bakel, Hester A. Gietema, Patricia M. Stassen, Harry R. Gosker, Debbie Gach, Joop P. van den Bergh, Frits H. M. van Osch, Annemie M. W. J. Schols, Rosanne J. H. C. G. Beijers
CHEST (2023)
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study
Shahab Abtahi, Romin Pajouheshnia, Carlos E. Duran, Judit Riera-Arnau, Magdalena Gamba, Ema Alsina, Vjola Hoxhaj, Morten Andersen, Claudia Bartolini, Sarah Brogger Kristiansen, Jeremy Brown, Christine Erikstrup Hallgreen, Patricia Garcia-Poza, Helga Gardarsdottir, Rosa Gini, Anna Girardi, Emily Holthuis, Consuelo Huerta, Luisa Ibanez, Giorgio Limoncella, Mar Martin-Perez, Olga Paoletti, Giuseppe Roberto, Patrick Souverein, Karin M. A. Swart, Kevin Wing, Miriam Sturkenboom, Olaf Klungel
DRUG SAFETY (2023)
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
Rasmus Westermann, Rene Lindholm Cordtz, Kirsten Duch, Lene Mellemkjaer, Merete Lund Hetland, Andrea Michelle Burden, Lene Dreyer
RHEUMATOLOGY (2023)
An explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects
Dominik Stampfli, Rebecca Dommrich, Sharon Orbach-Zinger, Andrea M. Burden, Michael Heesen
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2023)
Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data
Natalia Konstantelos, Andrea M. Burden, Angela M. Cheung, Sandra Kim, Paul Grootendorst, Suzanne M. Cadarette
PHARMACY (2023)
JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register
Maria Luisa Faquetti, Enriqueta Vallejo-Yague, Rene Cordtz, Lene Dreyer, Andrea M. Burden
PLOS ONE (2023)
Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis
Carlos E. Duran, Judit Riera-Arnau, Shahab Abtahi, Romin Pajouheshnia, Vjola Hoxhaj, Magdalena Gamba, Ema Alsina, Mar Martin-Perez, Patricia Garcia-Poza, Ana Llorente-Garcia, Diana Gonzalez-Bermejo, Luisa Ibanez, Monica Sabate, Xavier Vidal, Elena Ballarin, Gabriel Sanfelix-Gimeno, Clara Rodriguez-Bernal, Salvador Peiro, Anibal Garcia-Sempere, Francisco Sanchez-Saez, Valentina Ientile, Ylenia Ingrasciotta, Claudio Guarneri, Matilde Tanaglia, Michele Tari, Ron Herings, Eline Houben, Karin Swart-Polinder, Emily Holthuis, Consuelo Huerta, Rosa Gini, Giuseppe Roberto, Claudia Bartolini, Olga Paoletti, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Morten Andersen, Sarah Brogger Kristiansen, Christine Erikstrup Hallgreen, Olaf Klungel, Miriam Sturkenboom
FRONTIERS IN PHARMACOLOGY (2023)
Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures
Sanne Treurniet, Melissa S. A. M. Bevers, Caroline E. E. Wyers, Dimitra Micha, Bernd P. P. Teunissen, Mariet W. W. Elting, Joop P. P. van den Bergh, Elisabeth M. W. Eekhoff
CALCIFIED TISSUE INTERNATIONAL (2023)
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab
Theresa Burkard, Enriqueta Vallejo-Yague, Kim Lauper, Axel Finckh, Thomas Hugle, Andrea M. Burden
RMD OPEN (2023)